Search

Your search keyword '"Jingcong Zhang"' showing total 2 results
Start Over Author "Jingcong Zhang" Topic azithromycin
2 results on '"Jingcong Zhang"'

1. Giant Hepatic Hemangioma Regressed Significantly Without Surgical Management: A Case Report and Literature Review

Author

Jingcong Zhang, Zuyang Ye, Lei Tan, and Jinmei Luo

Subjects
giant hepatic hemangioma, vascular endothelial growth factor, azithromycin, case repot, congenital vascular anomalies, Medicine (General), R5-920
Abstract

Hepatic hemangioma (HH) is a congenital vascular anomaly comprising networks of abnormal blood and/or lymphatic vessels with endothelial cell proliferation. Their pathophysiology is not fully understood, and no specific drug is available to treat them. Conservative management, which limits observation, is preferred for most patients. A HH larger than 4 cm is considered a giant HH that may be treated using surgery ranging from embolization to hepatic resection or liver transplantation. Here, we describe a case with multiple and giant HHs that regressed significantly after treatment with azithromycin (AZM). A systematic literature review of HH and the effects of AZM on angiogenesis was then conducted.

Published
2021
Full Text
View/download PDF

2. Giant Hepatic Hemangioma Regressed Significantly Without Surgical Management: A Case Report and Literature Review

Author

Zuyang Ye, Jingcong Zhang, Jinmei Luo, and Lei Tan

Subjects
Medicine (General), Pathology, medicine.medical_specialty, giant hepatic hemangioma, Angiogenesis, medicine.medical_treatment, case repot, Case Report, Liver transplantation, Azithromycin, chemistry.chemical_compound, R5-920, medicine, Embolization, azithromycin, vascular endothelial growth factor, business.industry, General Medicine, Pathophysiology, Vascular endothelial growth factor, Endothelial stem cell, Lymphatic system, congenital vascular anomalies, chemistry, Medicine, business, medicine.drug
Abstract

Hepatic hemangioma (HH) is a congenital vascular anomaly comprising networks of abnormal blood and/or lymphatic vessels with endothelial cell proliferation. Their pathophysiology is not fully understood, and no specific drug is available to treat them. Conservative management, which limits observation, is preferred for most patients. A HH larger than 4 cm is considered a giant HH that may be treated using surgery ranging from embolization to hepatic resection or liver transplantation. Here, we describe a case with multiple and giant HHs that regressed significantly after treatment with azithromycin (AZM). A systematic literature review of HH and the effects of AZM on angiogenesis was then conducted.

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results